Micro Emerging Active

Barclays podnosi cel cenową Ionis do $106

New narrative with limited coverage — still forming.

Ocena
0,3
Dynamika
▲ 0,0
Artykuły
3
Źródła
1

Sentiment Timeline

Event Timeline

Kwi 02, 2026
Barclays Reaffirms Equal Weight Rating for uniQure (QURE) Neutral
Mar 31, 2026
Cantor Fitzgerald Cuts PT on Apellis Pharmaceuticals (APLS) to $31 From $35 … Bearish
Mar 26, 2026
Why Barclays Thinks Ionis Is Headed for a 45% Surge From $73 … Neutral

Oś czasu

Pierwsze pojawienieMar 26, 2026
Ostatnia aktualizacjaMar 26, 2026